| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 5.50e-05 | 1390 | 34 | 10 | GO:0045944 | |
| GeneOntologyCellularComponent | chromatin | 4.53e-04 | 1480 | 34 | 9 | GO:0000785 | |
| GeneOntologyCellularComponent | Golgi lumen | 7.34e-04 | 109 | 34 | 3 | GO:0005796 | |
| MousePheno | abnormal digestive secretion | 4.51e-05 | 35 | 28 | 3 | MP:0000501 | |
| MousePheno | abnormal locomotor coordination | 6.26e-05 | 726 | 28 | 8 | MP:0003312 | |
| MousePheno | hypochlorhydria | 8.07e-05 | 7 | 28 | 2 | MP:0008001 | |
| Domain | SEA | 2.89e-04 | 14 | 34 | 2 | SM00200 | |
| Domain | - | 3.33e-04 | 15 | 34 | 2 | 3.30.70.960 | |
| Domain | PHD | 3.40e-04 | 75 | 34 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 3.97e-04 | 79 | 34 | 3 | IPR019787 | |
| Domain | PHD | 5.62e-04 | 89 | 34 | 3 | SM00249 | |
| Domain | Znf_PHD | 6.00e-04 | 91 | 34 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.80e-04 | 95 | 34 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 7.02e-04 | 96 | 34 | 3 | PS01359 | |
| Domain | SEA | 7.26e-04 | 22 | 34 | 2 | PF01390 | |
| Domain | SEA | 7.95e-04 | 23 | 34 | 2 | PS50024 | |
| Domain | SEA_dom | 7.95e-04 | 23 | 34 | 2 | IPR000082 | |
| Domain | - | 1.23e-03 | 449 | 34 | 5 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.36e-03 | 459 | 34 | 5 | IPR013083 | |
| Domain | Znf-RING_LisH | 1.74e-03 | 34 | 34 | 2 | IPR027370 | |
| Domain | zf-RING_UBOX | 1.74e-03 | 34 | 34 | 2 | PF13445 | |
| Domain | Znf_FYVE_PHD | 2.39e-03 | 147 | 34 | 3 | IPR011011 | |
| Domain | BBOX | 6.99e-03 | 69 | 34 | 2 | SM00336 | |
| Domain | - | 7.19e-03 | 218 | 34 | 3 | 1.10.10.10 | |
| Domain | - | 7.39e-03 | 71 | 34 | 2 | 4.10.45.10 | |
| Domain | zf-B_box | 7.59e-03 | 72 | 34 | 2 | PF00643 | |
| Domain | ZF_BBOX | 9.30e-03 | 80 | 34 | 2 | PS50119 | |
| Domain | Znf_B-box | 9.53e-03 | 81 | 34 | 2 | IPR000315 | |
| Domain | WHTH_DNA-bd_dom | 9.56e-03 | 242 | 34 | 3 | IPR011991 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.07e-06 | 16 | 26 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 3.72e-06 | 17 | 26 | 3 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 7.25e-06 | 21 | 26 | 3 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.63e-06 | 23 | 26 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.41e-05 | 26 | 26 | 3 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.78e-04 | 60 | 26 | 3 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.96e-04 | 62 | 26 | 3 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.58e-04 | 68 | 26 | 3 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.03e-03 | 109 | 26 | 3 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.08e-03 | 111 | 26 | 3 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.11e-03 | 140 | 26 | 3 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.24e-03 | 143 | 26 | 3 | M27275 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 6.34e-03 | 65 | 26 | 2 | M39682 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ETV1 MAGI1 AFF1 RIPOR1 TLK1 CAMTA1 KAT6B SLC31A1 SLC30A4 FOXJ3 GLIS1 PCDH11Y | 1.75e-08 | 1489 | 36 | 12 | 28611215 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.58e-07 | 430 | 36 | 7 | 35044719 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 8.22e-07 | 18 | 36 | 3 | 18834073 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 27003157 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 24039759 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 16194893 | ||
| Pubmed | Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival. | 1.04e-06 | 2 | 36 | 2 | 24551091 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 23687433 | ||
| Pubmed | Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function. | 1.04e-06 | 2 | 36 | 2 | 24968021 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 23925696 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30011875 | ||
| Pubmed | Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis. | 1.04e-06 | 2 | 36 | 2 | 26246541 | |
| Pubmed | Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer. | 1.04e-06 | 2 | 36 | 2 | 24879526 | |
| Pubmed | Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge. | 1.04e-06 | 2 | 36 | 2 | 27327081 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 25454345 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 33462738 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 25531720 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20598042 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23446997 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22402132 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23053434 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19924550 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19270645 | ||
| Pubmed | Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. | 3.12e-06 | 3 | 36 | 2 | 12893366 | |
| Pubmed | Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer. | 3.12e-06 | 3 | 36 | 2 | 17852076 | |
| Pubmed | Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study. | 3.12e-06 | 3 | 36 | 2 | 21792548 | |
| Pubmed | Mucin expression in reactive gastropathy: an immunohistochemical analysis. | 3.12e-06 | 3 | 36 | 2 | 17227128 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 35879412 | ||
| Pubmed | Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer. | 3.12e-06 | 3 | 36 | 2 | 34621407 | |
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 3.12e-06 | 3 | 36 | 2 | 17592322 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23163606 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 27483328 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 26196062 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 23886210 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 24939955 | ||
| Pubmed | TRIM50 protein regulates vesicular trafficking for acid secretion in gastric parietal cells. | 3.12e-06 | 3 | 36 | 2 | 22872646 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21596555 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21940751 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 19556244 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 33154304 | ||
| Pubmed | Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. | 6.24e-06 | 4 | 36 | 2 | 24603585 | |
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 6.24e-06 | 4 | 36 | 2 | 24901817 | |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 6.24e-06 | 4 | 36 | 2 | 27298226 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 36367122 | ||
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 6.24e-06 | 4 | 36 | 2 | 39024979 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 28011514 | ||
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 6.24e-06 | 4 | 36 | 2 | 17401217 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 25563498 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 25298197 | ||
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 6.24e-06 | 4 | 36 | 2 | 20929551 | |
| Pubmed | Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors. | 7.10e-06 | 36 | 36 | 3 | 25715395 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 20049703 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 19383238 | ||
| Pubmed | Williams-Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase. | 1.04e-05 | 5 | 36 | 2 | 18398435 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 18609108 | ||
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 1.04e-05 | 5 | 36 | 2 | 16475027 | |
| Pubmed | 1.14e-05 | 42 | 36 | 3 | 26166575 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.25e-05 | 774 | 36 | 7 | 15302935 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 29604308 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 19110483 | ||
| Pubmed | Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. | 1.56e-05 | 6 | 36 | 2 | 9647693 | |
| Pubmed | TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization. | 1.56e-05 | 6 | 36 | 2 | 36178239 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 26025256 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 18547559 | ||
| Pubmed | 7.07e-05 | 77 | 36 | 3 | 21525287 | ||
| Pubmed | Neurogenin3 cooperates with Foxa2 to autoactivate its own expression. | 8.07e-05 | 13 | 36 | 2 | 23471965 | |
| Pubmed | 8.74e-05 | 441 | 36 | 5 | 12853948 | ||
| Pubmed | Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse. | 9.41e-05 | 14 | 36 | 2 | 20847152 | |
| Pubmed | 1.24e-04 | 16 | 36 | 2 | 22792322 | ||
| Pubmed | 1.24e-04 | 16 | 36 | 2 | 21266405 | ||
| Pubmed | 1.40e-04 | 17 | 36 | 2 | 16472605 | ||
| Pubmed | 1.58e-04 | 18 | 36 | 2 | 19403103 | ||
| Pubmed | 1.66e-04 | 808 | 36 | 6 | 20412781 | ||
| Pubmed | Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts. | 1.96e-04 | 20 | 36 | 2 | 26033091 | |
| Pubmed | 1.96e-04 | 20 | 36 | 2 | 21888903 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 2.32e-04 | 544 | 36 | 5 | 28473536 | |
| Pubmed | 2.38e-04 | 22 | 36 | 2 | 18448648 | ||
| Pubmed | TCF7L2 regulates postmitotic differentiation programmes and excitability patterns in the thalamus. | 2.38e-04 | 22 | 36 | 2 | 32675279 | |
| Pubmed | 2.83e-04 | 24 | 36 | 2 | 22529374 | ||
| Pubmed | 2.83e-04 | 24 | 36 | 2 | 23852729 | ||
| Pubmed | 3.08e-04 | 25 | 36 | 2 | 21784065 | ||
| Pubmed | Zic1 and Zic3 regulate medial forebrain development through expansion of neuronal progenitors. | 3.08e-04 | 25 | 36 | 2 | 17507568 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.11e-04 | 908 | 36 | 6 | 19274049 | |
| Pubmed | 3.87e-04 | 28 | 36 | 2 | 32868762 | ||
| Pubmed | 3.87e-04 | 28 | 36 | 2 | 21658586 | ||
| Pubmed | 4.16e-04 | 29 | 36 | 2 | 24105743 | ||
| Pubmed | Planar cell polarity controls pancreatic beta cell differentiation and glucose homeostasis. | 5.07e-04 | 32 | 36 | 2 | 23177622 | |
| Pubmed | Mechanosignalling via integrins directs fate decisions of pancreatic progenitors. | 5.07e-04 | 32 | 36 | 2 | 30487608 | |
| Pubmed | 5.72e-04 | 34 | 36 | 2 | 26771085 | ||
| Pubmed | 5.72e-04 | 34 | 36 | 2 | 20181579 | ||
| Pubmed | Pancreatic Cell Fate Determination Relies on Notch Ligand Trafficking by NFIA. | 6.07e-04 | 35 | 36 | 2 | 30590051 | |
| Pubmed | 6.42e-04 | 36 | 36 | 2 | 25063451 | ||
| Pubmed | 6.42e-04 | 36 | 36 | 2 | 33737325 | ||
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 8.33e-04 | 41 | 36 | 2 | 15561718 | |
| Pubmed | Parcellation of the striatal complex into dorsal and ventral districts. | 8.74e-04 | 42 | 36 | 2 | 32170006 | |
| Pubmed | 8.74e-04 | 42 | 36 | 2 | 19449303 | ||
| Pubmed | WT1-mediated gene regulation in early urogenital ridge development. | 1.00e-03 | 45 | 36 | 2 | 18391535 | |
| Cytoband | 7q11.23 | 6.21e-05 | 97 | 36 | 3 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 1.26e-03 | 271 | 36 | 3 | chr7q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q22 | 1.44e-03 | 71 | 36 | 2 | chr1q22 | |
| GeneFamily | CD molecules|Mucins | 2.36e-06 | 21 | 23 | 3 | 648 | |
| GeneFamily | PHD finger proteins | 1.97e-04 | 90 | 23 | 3 | 88 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 6.43e-03 | 95 | 23 | 2 | 59 | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 8.72e-06 | 162 | 36 | 4 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-05 | 184 | 36 | 4 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 190 | 36 | 4 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 190 | 36 | 4 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 160 | 36 | 3 | 7064af50fc10e3ea03badf415306222b74db0f95 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-04 | 160 | 36 | 3 | ac5d573c135d66d6adddd42dfddd9d3e01532172 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-04 | 160 | 36 | 3 | b81d218c20fe37921cf3c6c7db2da3bfd367230a | |
| ToppCell | metastatic_Brain-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.94e-04 | 161 | 36 | 3 | e6e294b4ba911c1327664f1a0f93207096c6de03 | |
| ToppCell | Control-Epithelial-Ionocyte|Control / Disease state, Lineage and Cell class | 3.05e-04 | 163 | 36 | 3 | bf09fa39bf3e6b3a776d5e79c30c96df572956a3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.16e-04 | 165 | 36 | 3 | 83095377aedf960c05baa523869bdbd2b0a05f2d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-04 | 167 | 36 | 3 | 31633899aae852873a4887e72c621474b0a51a33 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-04 | 173 | 36 | 3 | 3aa1d28d4814798a772808ed29e1dbbdf92abd03 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-04 | 173 | 36 | 3 | e8afef5ae68983eb8d6515b43952636a47e9d3d4 | |
| ToppCell | CV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 3.70e-04 | 174 | 36 | 3 | 26544cc5f51cb4dc1251e62d9f80b6c956194d38 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-04 | 175 | 36 | 3 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-04 | 175 | 36 | 3 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 3.82e-04 | 176 | 36 | 3 | 5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-epithelial_progenitor_cell-CLDN10+_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-04 | 179 | 36 | 3 | 7eca1e19ae6b5b1f18c721691dc3e860705628f2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-04 | 179 | 36 | 3 | 6405010e8136a4d9bab356f628e36e3194911112 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-04 | 182 | 36 | 3 | 40539ade8c3cd12b61f1cd0d493828e58282796b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-04 | 184 | 36 | 3 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.35e-04 | 184 | 36 | 3 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-04 | 185 | 36 | 3 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 188 | 36 | 3 | 842982de2197770f999a70083ed9fca40ac22d79 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.63e-04 | 188 | 36 | 3 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 4.63e-04 | 188 | 36 | 3 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 188 | 36 | 3 | a0815eaf68eedd6e5ec4af520df80a6ab4eb0864 | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.70e-04 | 189 | 36 | 3 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-04 | 190 | 36 | 3 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-04 | 190 | 36 | 3 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.85e-04 | 191 | 36 | 3 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 4.85e-04 | 191 | 36 | 3 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-04 | 191 | 36 | 3 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.85e-04 | 191 | 36 | 3 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-04 | 191 | 36 | 3 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.85e-04 | 191 | 36 | 3 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.85e-04 | 191 | 36 | 3 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.85e-04 | 191 | 36 | 3 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-04 | 191 | 36 | 3 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-04 | 191 | 36 | 3 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.85e-04 | 191 | 36 | 3 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 4.85e-04 | 191 | 36 | 3 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-04 | 191 | 36 | 3 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 4.85e-04 | 191 | 36 | 3 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 4.85e-04 | 191 | 36 | 3 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-04 | 191 | 36 | 3 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.85e-04 | 191 | 36 | 3 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.92e-04 | 192 | 36 | 3 | dcf2d0c2e8868104c4dba410456207f0d947029a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-04 | 192 | 36 | 3 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.92e-04 | 192 | 36 | 3 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.92e-04 | 192 | 36 | 3 | a22952b885c8a7704a4a9602fa03e4f2c786bf75 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-04 | 192 | 36 | 3 | d5ec4cdb15620a5abfc83577353501186c2bc86a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.00e-04 | 193 | 36 | 3 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 193 | 36 | 3 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-04 | 193 | 36 | 3 | 605fc2a25ed6846fb283b2918cfed98df6039d6b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-04 | 193 | 36 | 3 | 5da60321bcf761913eb30779b6d8b1e933c5e51e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.08e-04 | 194 | 36 | 3 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | C_06|World / shred on cell type and cluster | 5.08e-04 | 194 | 36 | 3 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 5.15e-04 | 195 | 36 | 3 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-04 | 195 | 36 | 3 | 576142b4e75457c0973051bccc4163bd624496af | |
| ToppCell | 3'-Airway_Nasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-04 | 195 | 36 | 3 | 7ffbdbe95b248699bf6300322d084d21a4a4b1b8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-04 | 195 | 36 | 3 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-04 | 195 | 36 | 3 | 8f151066ad3ebd9661ea0b733f03c2ce1518f9ad | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-04 | 195 | 36 | 3 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | Nasal_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.15e-04 | 195 | 36 | 3 | 7509b980b6b293df02bec619ef5b83a6c7b49c03 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 5.15e-04 | 195 | 36 | 3 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | 3'-Airway_Nasal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-04 | 196 | 36 | 3 | eadc3e60104214cb5f6cfb098a5c5ea0f83d15bd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-04 | 196 | 36 | 3 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.23e-04 | 196 | 36 | 3 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.31e-04 | 197 | 36 | 3 | 3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 5.31e-04 | 197 | 36 | 3 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.39e-04 | 198 | 36 | 3 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.39e-04 | 198 | 36 | 3 | 361f3062f73a0add16dd6fbe927698416515879f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.46e-04 | 199 | 36 | 3 | 1e693d7bb481bf03a943b460a69787229625d7b1 | |
| ToppCell | moderate-Epithelial-Secretory-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.55e-04 | 200 | 36 | 3 | 6f29ef9dcf126c5c19386f6aa9a20c38a2c8ccc8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 5.55e-04 | 200 | 36 | 3 | 70c2e577efb6b6fe8f9d970d7ecc470788efb85b | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.55e-04 | 200 | 36 | 3 | 8f179b5768fd504af6dd6f6749a0bed7b689e77f | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-04 | 200 | 36 | 3 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.55e-04 | 200 | 36 | 3 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| Drug | Contact Lens Solutions | 2.16e-06 | 2 | 34 | 2 | ctd:D018639 | |
| Drug | Boric Acids | 6.49e-06 | 3 | 34 | 2 | ctd:D001888 | |
| Drug | Demecarium bromide [56-94-0]; Up 200; 5.6uM; HL60; HG-U133A | 1.05e-05 | 197 | 34 | 5 | 1781_UP | |
| Drug | Chloramphenicol [56-75-7]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.07e-05 | 198 | 34 | 5 | 5047_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.12e-04 | 168 | 34 | 4 | 6820_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.14e-04 | 169 | 34 | 4 | 5231_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.31e-04 | 175 | 34 | 4 | 1014_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.34e-04 | 176 | 34 | 4 | 7499_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.42e-04 | 179 | 34 | 4 | 6910_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 188 | 34 | 4 | 6451_DN | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.83e-04 | 191 | 34 | 4 | 7220_DN | |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.86e-04 | 192 | 34 | 4 | 3375_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; PC3; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 4653_DN | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 6514_DN | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 4593_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 4591_UP | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 6619_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; HL60; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 2396_DN | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; HL60; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 3083_UP | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 7137_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; PC3; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 4673_UP | |
| Drug | Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 7334_UP | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 6219_UP | |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.06e-04 | 197 | 34 | 4 | 4265_DN | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 6656_UP | |
| Drug | sulindac; Down 200; 50uM; MCF7; HG-U133A | 2.10e-04 | 198 | 34 | 4 | 307_DN | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 5737_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 3175_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 2000uM; MCF7; HG-U133A | 2.14e-04 | 199 | 34 | 4 | 346_DN | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 7518_DN | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 4008_UP | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 4228_DN | |
| Drug | Ciprofibrate [52214-84-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 6218_UP | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 7290_UP | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.18e-04 | 200 | 34 | 4 | 6836_UP | |
| Disease | dry eye syndrome (is_marker_for) | 6.47e-05 | 10 | 36 | 2 | DOID:10140 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 6.60e-05 | 64 | 36 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Myeloid Leukemia | 2.19e-04 | 18 | 36 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.19e-04 | 18 | 36 | 2 | C0023466 | |
| Disease | pancreatic cancer (is_marker_for) | 2.56e-04 | 101 | 36 | 3 | DOID:1793 (is_marker_for) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.87e-04 | 105 | 36 | 3 | DOID:9352 (implicated_via_orthology) | |
| Disease | peptic ulcer disease | 7.46e-04 | 33 | 36 | 2 | MONDO_0004247 | |
| Disease | Prostatic Neoplasms | 8.61e-04 | 616 | 36 | 5 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.61e-04 | 616 | 36 | 5 | C0376358 | |
| Disease | Mitral valve prolapse | 8.88e-04 | 36 | 36 | 2 | HP_0001634 | |
| Disease | dyslexia | 1.02e-03 | 162 | 36 | 3 | EFO_0005424 | |
| Disease | Testicular Germ Cell Tumor | 3.60e-03 | 73 | 36 | 2 | EFO_1000566 | |
| Disease | Moderate albuminuria | 4.31e-03 | 80 | 36 | 2 | HP_0012594 | |
| Disease | susceptibility to plantar warts measurement | 5.42e-03 | 90 | 36 | 2 | EFO_0008406 | |
| Disease | hypertrophic cardiomyopathy | 5.65e-03 | 92 | 36 | 2 | EFO_0000538 | |
| Disease | mean fractional anisotropy measurement | 6.02e-03 | 95 | 36 | 2 | EFO_0008399 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 6.02e-03 | 95 | 36 | 2 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | Adenoid Cystic Carcinoma | 6.65e-03 | 100 | 36 | 2 | C0010606 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 7.04e-03 | 103 | 36 | 2 | EFO_0008595, EFO_0020944 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSSFSQTGHSPHIHQ | 596 | Q9Y6Y1 | |
| NSAPHSSSTSHLHHP | 71 | Q9UIF9 | |
| TGAQSTAHPPVSTHH | 466 | P54259 | |
| HSSPSHTPTRHGRNT | 1581 | Q96BY7 | |
| SHGTHSQSTPPQHSS | 281 | Q8N0U7 | |
| HSSPVSSVHSHPGQS | 1596 | Q8WYB5 | |
| HSSVSIHSQPSGHTP | 6026 | Q8WXI7 | |
| TPTSLHSHTSSTHHP | 1521 | Q6W4X9 | |
| HSHTSSTHHPEVTPT | 1526 | Q6W4X9 | |
| HPHTTLPTHVPSFST | 1831 | Q6W4X9 | |
| TSLPYHTSSTHHPEV | 1916 | Q6W4X9 | |
| HTSSTHHPEVTPTST | 1921 | Q6W4X9 | |
| QHSVSSHRSLHTASP | 746 | Q96QZ7 | |
| SHRSLHTASPSHSTQ | 751 | Q96QZ7 | |
| STHHSSVPPLTSSNH | 1016 | P15941 | |
| SPLHHASPNSTHTPK | 146 | P50549 | |
| SPSHVQSSPSSHSNH | 1291 | Q8IZD2 | |
| PSHSHSHSTPSSSIS | 506 | Q5MIZ7 | |
| SVLPHSTLSTLSHHP | 11 | P57721 | |
| HHTTTKTHNPGSLPT | 1271 | Q6WRI0 | |
| QHSPSSTVSTHPHSN | 331 | Q9UPW0 | |
| STPPAHSSVFHHSVK | 126 | Q5SR53 | |
| SHSHPSLPASSLARH | 366 | Q53ET0 | |
| LSPTSHPSSANHHFS | 346 | Q8ND61 | |
| LDATTSSHHHLSPLP | 431 | Q8NBF1 | |
| STMQPSHHHPTTSAS | 16 | O15431 | |
| HSPPLSQASTQHHSP | 1166 | Q9BZA8 | |
| PPVSTLTNIHSLSHH | 411 | P35680 | |
| TSLHSPSNTSAPHSQ | 236 | Q16563 | |
| PFSPHSSPSFSHHRT | 121 | Q66K80 | |
| SIPSSSFHTSVHHQS | 101 | P51825 | |
| SHQHHPVTPVSTVCS | 116 | Q86UV6 | |
| PQNSHSHSTPSSSVR | 171 | Q9UKI8 | |
| TQSCHPHLSPSHPVS | 256 | Q6NTF9 | |
| STADHSATQHPTQPH | 841 | Q92610 | |
| PSVHPHSSHSNRNSA | 1216 | Q92545 | |
| SLSPSSSAVHHTAGH | 421 | Q15915 | |
| HRHSHSHSLPSNSPT | 241 | O14863 | |
| SHQHHPVTPVSTVCS | 116 | Q86UV7 | |
| HTSTSPTHTPTSPTH | 621 | Q6ZS17 | |
| SCPSQHTHTHPSPTN | 181 | O95416 |